Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Metabolic reprogramming during hyperammonemia targets mitochondrial function and postmitotic senescence
Avinash Kumar, Nicole Welch, Saurabh Mishra, Annette Bellar, Rafaella Nasciemento Silva, Ling Li, Shashi Shekhar Singh, Mary Sharkoff, Alexis Kerr, Aruna Kumar Chelluboyina, Jinendiran Sekar, Amy H. Attaway, Charles Hoppel, Belinda Willard, Gangarao Davuluri, Srinivasan Dasarathy
Avinash Kumar, Nicole Welch, Saurabh Mishra, Annette Bellar, Rafaella Nasciemento Silva, Ling Li, Shashi Shekhar Singh, Mary Sharkoff, Alexis Kerr, Aruna Kumar Chelluboyina, Jinendiran Sekar, Amy H. Attaway, Charles Hoppel, Belinda Willard, Gangarao Davuluri, Srinivasan Dasarathy
View: Text | PDF
Research Article Cell biology Hepatology

Metabolic reprogramming during hyperammonemia targets mitochondrial function and postmitotic senescence

  • Text
  • PDF
Abstract

Ammonia is a cytotoxic metabolite with pleiotropic molecular and metabolic effects, including senescence induction. During dysregulated ammonia metabolism, which occurs in chronic diseases, skeletal muscle becomes a major organ for nonhepatocyte ammonia uptake. Muscle ammonia disposal occurs in mitochondria via cataplerosis of critical intermediary metabolite α-ketoglutarate, a senescence-ameliorating molecule. Untargeted and mitochondrially targeted data were analyzed by multiomics approaches. These analyses were validated experimentally to dissect the specific mitochondrial oxidative defects and functional consequences, including senescence. Responses to ammonia lowering in myotubes and in hyperammonemic portacaval anastomosis rat muscle were studied. Whole-cell transcriptomics integrated with whole-cell, mitochondrial, and tissue proteomics showed distinct temporal clusters of responses with enrichment of oxidative dysfunction and senescence-related pathways/proteins during hyperammonemia and after ammonia withdrawal. Functional and metabolic studies showed defects in electron transport chain complexes I, III, and IV; loss of supercomplex assembly; decreased ATP synthesis; increased free radical generation with oxidative modification of proteins/lipids; and senescence-associated molecular phenotype–increased β-galactosidase activity and expression of p16INK, p21, and p53. These perturbations were partially reversed by ammonia lowering. Dysregulated ammonia metabolism caused reversible mitochondrial dysfunction by transcriptional and translational perturbations in multiple pathways with a distinct skeletal muscle senescence-associated molecular phenotype.

Authors

Avinash Kumar, Nicole Welch, Saurabh Mishra, Annette Bellar, Rafaella Nasciemento Silva, Ling Li, Shashi Shekhar Singh, Mary Sharkoff, Alexis Kerr, Aruna Kumar Chelluboyina, Jinendiran Sekar, Amy H. Attaway, Charles Hoppel, Belinda Willard, Gangarao Davuluri, Srinivasan Dasarathy

×

Figure 1

Whole-cell proteomics responses during hyperammonemia and following ammonia withdrawal in differentiated murine C2C12 myotubes.

Options: View larger image (or click on image) Download as PowerPoint
Whole-cell proteomics responses during hyperammonemia and following ammo...
(A) Clusters of differentially expressed protein (DEP) responses during hyperammonemia and following ammonia withdrawal (WD). Following a change with hyperammonemia (increase or decrease compared with untreated, UnT), WD results in progressive change in the same direction (compared with UnT controls) (clusters a and j), persistent change (b and i), partial reversal (d and g) or complete reversal to baseline (e and f), or overcorrection (c and h). (B) Heatmap of DEPs from whole-cell proteome from UnT, those treated with 24 hours ammonium acetate (24hAmAc), or after WD and the number of DEPs in each cluster. (C) Venn diagram of unique/shared DEPs (UnT, 24hAmAc, and WD). (D) Functional enrichment analysis of DEPs (24hAmAc vs. UnT) and changes that persist despite ammonia withdrawal (WD vs. UnT) with the network of DEPs within the senescence pathway. (E) Most enriched canonical pathways in the “completely reversed” clusters (e and f). that changes with 24hAmAc treatment but returns to baseline (UnT) with the network of DEPs within the senescence pathway. (F) Most enriched canonical pathways in the “persistent” clusters (b and i) that change with 24hAmAc and do not improve with WD. (G) Venn diagram of unique/shared DEPs in the myotube proteome data set overlaid with the genes in MitoCarta3.0 (yellow) and skeletal muscle expressed DEPs within MitoCarta3.0 (purple). Verified mitochondrial DEPs in the WD versus UnT comparison (red line), WD versus 24hAmAc (green line), and 24hAmAc versus UnT (blue line). Mitochondrial DEP numbers refer to those matched with MitoCarta3.0. All cellular experiments were done in n = 3 biological replicates. P value cutoff for DEPs was set at P < 0.05 using an unpaired 2-tailed Student’s t test. For D–F: green, decreased expression; red, increased expression. Significance cutoff for all pathways is –log(P value) ≥ 1.3 by a right-sided Fisher’s exact test. NS, not significantly enriched.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts